Black Rose Industries Ltd Growth Catalysts - SOIC x StockScans Report
as of Jul 2026
- Polyacrylamide solid project - The 10,000 MTPA polyacrylamide solid plant has moved to piloting and management targets commercial production during FY27, with the plant building already in place and R&D completed. At an estimated capex of ₹60-100 cr, this project adds a downstream manufacturing leg that can nearly double the addressable domestic market for solid-grade acrylamide products.
- Acrylamide liquid export ramp - Export demand began picking up in H2 Q1 FY27, supported by EU REACH registrations and Turkey KKDIK pre-registrations, with management expecting a strong ramp-up in export volumes. Exports comprised nearly 50% of acrylamide liquid sales at their peak, and returning to that mix at current 32,000 MTPA capacity would lift both volumes and realisations.
- NMA export expansion - NMA volumes nearly doubled in FY26 on higher offtake from the largest domestic buyer and new customer additions, and management identifies exports as the main growth driver since the export market is much larger than India. The product is stable for export, and the company is actively targeting overseas markets to build on its sole Indian merchant-supplier position.
- Merchant export order pipeline - A strong order pipeline for merchant exports is expected to convert into healthy performance during Q1 FY27, with volumes projected to increase through the year. US tariff measures exempt the company's products, and improving freight rates are reopening previously unviable markets.
- Distribution portfolio expansion - The distribution business, which contributed \~64% of FY26 revenue, is adding new products and expanding its end-user customer base, with increased focus on acrylonitrile sales already delivering improved profitability in H2 FY26. Management expects steady performance in FY27 with overall revenue supported by higher chemical prices.
- Dahej land bank - Registration of a \~20-acre land parcel near Dahej is nearing completion, earmarked for future manufacturing projects. Securing this land removes a site-selection bottleneck and creates a ready platform for the next wave of capacity expansion beyond the current Jhagadia site.
- New downstream acrylamide products - The R&D team is developing two new downstream products based on acrylamide chemistry, with management hopeful these will add to manufacturing offerings in coming quarters. These products would leverage existing acrylamide capacity and the new Navi Mumbai R&D facility to widen the manufacturing portfolio without large upfront capex.